|
HSF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.859400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.931800E-01 |
| Normal-vs-Stage2 |
2.040000E-01 |
| Normal-vs-Stage3 |
6.894100E-02 |
| Normal-vs-Stage4 |
6.565700E-02 |
| Stage1-vs-Stage2 |
7.882500E-02 |
| Stage1-vs-Stage3 |
1.173730E-02 |
| Stage1-vs-Stage4 |
5.618400E-02 |
| Stage2-vs-Stage3 |
7.397400E-01 |
| Stage2-vs-Stage4 |
1.999160E-01 |
| Stage3-vs-Stage4 |
2.676200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.072400E-01 |
| Normal-vs-AfricanAmerican |
1.204380E-01 |
| Normal-vs-Asian |
9.589800E-01 |
| Caucasian-vs-AfricanAmerican |
2.482600E-01 |
| Caucasian-vs-Asian |
8.119400E-01 |
| AfricanAmerican-vs-Asian |
5.558800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.245000E-01 |
| Normal-vs-Female |
1.044450E-02 |
| Male-vs-Female |
1.542060E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.282000E-01 |
| Normal-vs-Extreme_Weight |
3.266600E-01 |
| Normal-vs-Obese |
6.497700E-02 |
| Normal-vs-Extreme_Obese |
6.833000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.894400E-02 |
| Normal_Weight-vs-Obese |
7.037800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.535400E-01 |
| Extreme_Weight-vs-Obese |
3.197100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.251800E-01 |
| Obese-vs-Extreme_Obese |
2.223600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.110100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.146200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.554000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.609900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.434200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.616000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.924800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.204200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.613530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.874760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.208000E-01 |
| Normal-VS-Type2 PRCC |
9.722200E-01 |
| Normal-VS-KIRP CIMP |
3.400000E-03 |
| Normal-VS-Unclassified PRCC |
7.974800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.698000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.52129999997364E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
6.553800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.780180E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.913800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.781200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.126400E-01 |
| Normal-vs-N1 |
2.380300E-03 |
| Normal-vs-N2 |
9.956400E-01 |
| N0-vs-N1 |
1.196480E-03 |
| N0-vs-N2 |
8.270400E-01 |
| N1-vs-N2 |
1.688410E-01 |
|
|
